Evermay Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.6K | Hold |
150
| – | – | ﹤0.01% | 400 |
|
|
2025
Q1 | $16.8K | Hold |
150
| – | – | ﹤0.01% | 402 |
|
|
2024
Q4 | $13.9K | Hold |
150
| – | – | ﹤0.01% | 406 |
|
|
2024
Q3 | $12.6K | Hold |
150
| – | – | ﹤0.01% | 438 |
|
|
2024
Q2 | $10.3K | Hold |
150
| – | – | ﹤0.01% | 451 |
|
|
2024
Q1 | $11K | Sell |
150
-11
| -7% | -$806 | ﹤0.01% | 458 |
|
|
2023
Q4 | $13K | Buy |
161
+11
| +7% | +$891 | ﹤0.01% | 427 |
|
|
2023
Q3 | $11.2K | Hold |
150
| – | – | ﹤0.01% | 414 |
|
|
2023
Q2 | $11.6K | Hold |
150
| – | – | ﹤0.01% | 413 |
|
|
2023
Q1 | $12.4K | Hold |
150
| – | – | ﹤0.01% | 397 |
|
|
2022
Q4 | $12.9K | Hold |
150
| – | – | ﹤0.01% | 394 |
|
|
2022
Q3 | $9K | Hold |
150
| – | – | ﹤0.01% | 405 |
|
|
2022
Q2 | $9K | Hold |
150
| – | – | ﹤0.01% | 406 |
|
|
2022
Q1 | $9K | Hold |
150
| – | – | ﹤0.01% | 426 |
|
|
2021
Q4 | $11K | Hold |
150
| – | – | ﹤0.01% | 399 |
|
|
2021
Q3 | $10K | Hold |
150
| – | – | ﹤0.01% | 382 |
|
|
2021
Q2 | $10K | Buy |
+150
| New | +$10K | ﹤0.01% | 408 |
|